Patel Sunil
Director at LGND; Officer at OncoMed Pharmaceuticals Inc
- Sold, on record
- $11.1M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Aug 16, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- LGNDLIGAND PHARMACEUTICALS INCDirector
- OncoMed Pharmaceuticals IncOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- LGND46,878 shares
- OncoMed Pharmaceuticals Inc27,164 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LGNDPlan not statedMar 19, 2015 2015
Sold 4,591 shares at $74.42 ($342k)
Patel Sunil, Director
Sold 11% of holdings ($3.1M position)37,100 shares leftFirst sale on recordFiling
- 2 Form 4 sale OncoMed Pharmaceuticals IncUnusualMar 20, 2015 +1 day
Sold 18,000 shares at $27.76 ($500k)
Patel Sunil, Officer
Sold 47.4% of holdings ($1.1M position)20,000 shares leftFirst sale on recordFiling
- 3 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedJan 7, 2016 +293 days
Sold 2,162 shares at $22.28 ($48k)
Patel Sunil, Officer
Sold 10.8% of holdings ($446k position)17,838 shares leftFiling
- 4 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedApr 4, 2017 +453 days
Sold 5,754 shares at $9.06 ($52k)
Patel Sunil, Officer
Sold 19% of holdings ($275k position)24,584 shares leftFiling
- 5 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 10, 2017 +189 days
Sold 1,248 shares at $4.24 ($5k)
Patel Sunil, Officer
Sold 1.8% of holdings ($295k position)68,336 shares leftFiling
- 6 Form 4 sale LGNDUnusualAug 16, 2018 +310 days
Sold 42,287 shares at $240.05 ($10.2M)
Patel Sunil, Director
Sold 63.3% of holdings ($16M position)24,524 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2018 | Aug 17, 2018 | LGND | Director | Form 4 sale | 42,287 | $10.2M | 63.3% | Unusual | SEC |
| Oct 10, 2017 | Oct 12, 2017 | OncoMed Pharmaceuticals Inc | Officer | Form 4 sale | 1,248 | $5k | 1.8% | Plan not stated | SEC |
| Apr 4, 2017 | Apr 5, 2017 | OncoMed Pharmaceuticals Inc | Officer | Form 4 sale | 5,754 | $52k | 19.0% | Plan not stated | SEC |
| Jan 7, 2016 | Jan 8, 2016 | OncoMed Pharmaceuticals Inc | Officer | Form 4 sale | 2,162 | $48k | 10.8% | Plan not stated | SEC |
| Mar 20, 2015 | Mar 23, 2015 | OncoMed Pharmaceuticals Inc | Officer | Form 4 sale | 18,000 | $500k | 47.4% | Unusual | SEC |
| Mar 19, 2015 | Mar 20, 2015 | LGND | Director | Form 4 sale | 4,591 | $342k | 11.0% | Plan not stated | SEC |